Back

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - pro

30 August 2024 (16:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk? Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Catherine Gebhard

Inselspital - University of Bern, Bern (Switzerland)

2 More presentations in this session

Presentation thumbnail
Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - con
Professor M. Gulati (Houston, US)
Slides Video
Presentation thumbnail
Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - discussion
Video

Access the full session

Session thumbnail
Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Managing menopause in heart failure patients
17 May 2025
thumbnail
Congress Presentation
Association of contemporary hormonal contraception and the risk of arterial thrombosis
31 August 2024
thumbnail
Congress Presentation
Cardiac computed tomography is essential for my cardiovascular primary prevention practice: pro
1 September 2024
thumbnail
Congress Presentation
Cardiovascular issues in female patients receiving hormonal therapies / Problematiche cardiovascolari in donne in terapie ormonale
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources